24/7 Market News Snapshot 26 December, 2024 – Hoth Therapeutics, Inc. Common Stock (NASDAQ:HOTH)

December 26, 2024

DENVER, Colo., 26 December, 2024 (247marketnews.com) – (NASDAQ:HOTH) are discussed in this article.
Hoth Therapeutics, Inc. has recently been trading at $0.787 during pre-market sessions, remaining relatively stable with no change from the previous close. The trading activity has seen a significant volume of 6.21 million shares, indicating increased investor interest. However, the stock is currently in a bearish trend, having struggled to surpass critical resistance levels. Should Hoth fail to gain positive momentum, investors might anticipate further declines, making it essential to monitor for potential volume spikes and shifts in price action that could signal either a reversal or the continuation of this downward trend.

In a pivotal development, Hoth Therapeutics has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs and Emory University. This agreement secures Hoth the exclusive rights to a unique portfolio focused on leveraging Glial Cell Line-Derived Neurotrophic Factor as a novel strategy to address obesity and related health challenges. Robb Knie, CEO of Hoth Therapeutics, remarked on the significance of the partnership, emphasizing their commitment to bringing impactful therapies to market.

The agreement entails a structured pathway for the advancement of this innovative technology, from research to commercialization. Hoth Therapeutics is intent on utilizing its capabilities to develop these healthcare solutions comprehensively and effectively. Additionally, the company is enhancing its intellectual property with the acquisition of provisional patent protection for HT-001, its leading therapeutic aimed at cancer treatment, further positioning Hoth for future opportunities.

Through these strategic initiatives, Hoth Therapeutics continues to uphold its dedication to improving patient outcomes by fostering groundbreaking therapeutic solutions and forming key partnerships to drive advancements in healthcare.

Related news for (HOTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.